Israel Englander Aeglea Bio Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.11 - $0.46 $141,158 - $590,300	-1,283,262 Reduced 34.34%	2,453,221 $1.1 Million
Q1 2023 May 15, 2023	BUY	$0.29 - $0.61 $175,451 - $369,052	605,004 Added 19.32%	3,736,483 $1.08 Million
Q4 2022 Feb 14, 2023	BUY	$0.35 - $1.54 $810,882 - $3.57 Million	2,316,807 Added 284.39%	3,131,479 $1.41 Million
Q3 2022 Nov 14, 2022	BUY	$0.38 - $0.81 $111,247 - $237,133	292,757 Added 56.09%	814,672 $429,000
Q2 2022 Aug 15, 2022	BUY	$0.5 - $2.66 $49,000 - $260,682	98,001 Added 23.12%	521,915 $264,000
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $436,517 - $1.11 Million	233,432 Added 122.55%	423,914 $975,000
Q4 2021 Feb 14, 2022	SELL	$3.5 - $8.42 $1.21 Million - $2.9 Million	-344,740 Reduced 64.41%	190,482 $905,000
Q3 2021 Nov 15, 2021	SELL	$6.03 - $7.95 $48,016 - $63,305	-7,963 Reduced 1.47%	535,222 $4.26 Million
Q2 2021 Aug 16, 2021	BUY	$6.32 - $8.38 $1.09 Million - $1.44 Million	172,049 Added 46.36%	543,185 $3.78 Million
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $595,028 - $754,348	-88,022 Reduced 19.17%	371,136 $2.94 Million
Q4 2020 Feb 16, 2021	BUY	$7.02 - $9.83 $2.84 Million - $3.98 Million	404,647 Added 742.32%	459,158 $3.61 Million
Q3 2020 Nov 16, 2020	SELL	$6.51 - $9.33 $839,392 - $1.2 Million	-128,939 Reduced 70.29%	54,511 $386,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $679,759 - $1.87 Million	169,516 Added 1216.56%	183,450 $1.7 Million
Q1 2020 May 14, 2020	BUY	$3.51 - $8.48 $48,908 - $118,160	13,934 New	13,934 $65,000
Q3 2019 Nov 14, 2019	SELL	$6.42 - $9.0 $487,175 - $682,956	-75,884 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$6.1 - $8.78 $338,055 - $486,578	55,419 Added 270.8%	75,884 $520,000
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $36,276 - $52,214	5,947 Added 40.96%	20,465 $2.08 Million
Q1 2019 May 14, 2019	SELL	$7.6 - $9.4 $48,381 - $59,840	-6,366 Reduced 30.48%	14,518 $117,000
Q4 2018 Feb 14, 2019	BUY	$6.51 - $10.19 $135,954 - $212,807	20,884 New	20,884 $156,000
Q3 2018 Nov 14, 2018	SELL	$8.24 - $11.0 $3.93 Million - $5.24 Million	-476,478 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $3.17 Million - $4.38 Million	402,288 Added 542.24%	476,478 $5.04 Million
Q1 2018 May 15, 2018	BUY	$5.07 - $10.9 $306,030 - $657,934	60,361 Added 436.48%	74,190 $736,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $5.98 $55,316 - $82,697	13,829	13,829 $75,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account